UniQuest is The University of Queensland's main commercialisation company

We specialise in industry-university collaborations, global technology transfer, and provide access to UQ's world-class expertise, intellectual property and facilities.

Our Vision

To facilitate commercialisation to achieve profound commercial, environmental and social benefits as impact for UQ.

Our Mission

To commercialise UQ's intellectual property, expertise and research outcomes to create demonstrable value for UQ, for society, and to do so in a way that is financially self-sustaining.


UniQuest’s newly positioned and rebranded business is designed to build industry engagement and commercialisation outcomes for UQ

Our Channels to Market

Our Values

Act with Integrity

We act with honesty, integrity and professionalism and uphold the highest ethical standards. We are committed to transparency and accountability to our shareholders and customers.

We work in the best interests of UniQuest and the UniQuest team. Our personal interests are secondary to UniQuest's best interests.



We build long-term trusted relationships with our internal and external customers for mutual benefit.



We trust in the integrity, strength and ability of UniQuest and its staff to fulfil its promises and commitments. We respect our colleagues and partners and work together for shared success.



We are receptive to new ideas. We are accessible to our colleagues and partners to enable effective and positive working relationships and to respond to both personal needs and business opportunities.




We are

Client focussed
Our clients are the centre of our world. We listen, understand and tailor solutions.


We know that one size does not fit all when it comes to structuring research collaborations and commercial deals. We always want a valuable and enduring partnership so we are flexible about deal structures and seek win/win outcomes.
We come from industry and are highly networked so we are aware of issues affecting industry and are motivated to partner and solve real world problems.
Business savvy
We are staffed by professionals who understand industry needs and our place in the supply chain is between academia and industry.
Structured for results
We have structured our business into four easy to access market channels so that our clients don’t have to navigate the University corridors to find the world-class expertise and innovation they are seeking.
Local and global
We collaborate with clients who are small, medium and large, span every market sector and are in every corner of the globe.
Celebrating 30+ commercialisation stories after 30 years of business.


Our History

UQ’s seventh Vice-Chancellor Professor Brian Wilson, arrived at UQ and saw the tremendous potential of UQ’s cutting edge research in areas ranging from energy to mining and agriculture.  He saw the potential to commercialise research outcomes to solve industry problems and build UQ’s financial independence.
The vision of Vice-Chancellor Professor Brian Wilson led to the establishment of UniQuest in July 1984 as UQ’s research and expertise commercialisation company, wholly owned by UQ.  UniQuest started with one desk, two chairs, a telephone and seed funding of $155,000 from the University.
In its second year of business, UniQuest made a net profit of nearly $200,000 by commercialising a technology for the efficient conversion of sugar-cane syrup to ethanol and fructose and the economic conversion of waste products to protein.
UniQuest Managed its first commercial consultancy project.
UniQuest filed the patent application for the cervical cancer vaccine co-invented by Professor Ian Frazer, now a UQ Innovation Champion.
UniQuest’s Consulting & Research Division was formed.
UniQuest commercialised the cervical cancer vaccine technology with CSL who subsequently sublicensed it to Merck & Co., Inc. UniQuest’s International Development Division was formed.
UniQuest commercialised the magnetic resonance imaging technology of Professor Stuart Crozier, a UQ Innovation Champion.
The Positive Parenting Program developed by Professor Matt Sanders, another UQ Innovation Champion, was licensed to Triple P International to commercialise globally.
UniQuest ran its first Commercialisation Workshop, demonstrating its commitment to provide commercialisation awareness to UQ researchers, and has run this every year since. UniQuest and University of Wollongong enter into contractual arrangement – the first of its kind ever undertaken between two Australian universities – where UniQuest commercialises the intellectual property of the University of Wollongong.
The Pathfinder Proof of Concept funding program commenced.
Saw the first commercial sale of the Gardasil cervical cancer vaccine by Merck & Co., Inc.
UniQuest’s annual revenues had grown to $100 million.  UniQuest expanded to provide commercialisation services for 6 other Australian universities and research institutes.
UniQuest refocussed its core strategy and business objectives to maximise the impact of UQ’s research outcomes through commercialisation; and restructured its business and realigned its approach to service UQ only.


UniQuest’s newly positioned and rebranded business is designed to build industry engagement and commercialisation outcomes for UQ.


Available Innovations
Novel adjuvant to re-sensitise antibiotic-resistant bacteria to treat pyoderma

Researchers from The University of Queensland have identified adjuvants which can re-sensitise tetracycline-resistant strains of group A streptococcus and restore its activity in a skin infection model.

Active Filter Plasma

A Novel NOx and Particulate Matter Filter Using Non-Thermal Plasma (NTP)

Rapid Nucleic Acid Extraction

The ability to amplify and detect specific DNA sequences

Molecular Clamp: a novel protein vaccine for influenza, RSV, Ebola and other viruses

A Qualitative Method to Improve Alarm Management for Plant Safety and Efficiency

A novel, qualitative approach to analysis of alarms at each stage of the alarm system lifecycle.